GMED
Globus Medical, Inc. NYSE Listed Aug 3, 2012$79.23
+5.05%
vs $75.42
Mkt Cap $10.9B
52w Low $51.89
60.9% of range
52w High $96.82
50d MA $84.97
200d MA $80.90
P/E (TTM)
20.2x
EV/EBITDA
14.3x
P/B
2.3x
Debt/Equity
0.0x
ROE
11.8%
P/FCF
18.5x
RSI (14)
44.30
ATR (14)
$2.35
Beta
1.09
50d MA
$84.97
200d MA
$80.90
Avg Volume
2.0M
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
2560 General Armistead Avenue · Audubon, PA 19403 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | 0.92 | 1.12 | +21.7% | 85.07 | +0.6% | -8.4% | -1.6% | -0.7% | -0.7% | +2.2% | — |
| Feb 24, 2026 | AMC | 1.06 | 1.28 | +20.8% | 91.88 | +0.5% | +4.7% | +0.5% | -1.3% | -1.7% | -2.2% | — |
| Nov 6, 2025 | AMC | 0.78 | 1.18 | +51.1% | 61.71 | +29.6% | +35.9% | +2.9% | -1.6% | -0.3% | -0.8% | — |
| Aug 7, 2025 | AMC | 0.76 | 0.86 | +13.2% | 54.07 | +3.6% | +8.5% | +1.3% | +4.1% | +1.5% | -4.4% | — |
| May 8, 2025 | AMC | 0.74 | 0.68 | -8.6% | 72.46 | -15.9% | -23.0% | +5.7% | -1.3% | -0.1% | -0.6% | — |
| Feb 20, 2025 | AMC | 0.74 | 0.84 | +13.5% | 84.12 | -1.5% | -4.6% | -0.3% | -0.5% | +0.5% | -1.7% | — |
| Nov 5, 2024 | AMC | 0.65 | 0.83 | +28.3% | 75.58 | +7.8% | +9.4% | -0.9% | -1.3% | +1.4% | +1.7% | — |
| Aug 6, 2024 | AMC | 0.68 | 0.75 | +10.3% | 69.05 | +7.5% | +2.1% | +4.8% | -1.0% | -0.2% | -7.8% | — |
| May 7, 2024 | AMC | 0.57 | 0.72 | +27.0% | 51.36 | +13.3% | +20.2% | +4.3% | +0.6% | -1.5% | -1.4% | — |
| Feb 20, 2024 | AMC | 0.59 | 0.60 | +1.7% | 54.16 | -1.1% | +1.6% | +0.5% | +1.9% | -0.7% | +0.9% | — |
| Nov 7, 2023 | AMC | 0.54 | 0.57 | +5.6% | 46.19 | -1.8% | -0.7% | -4.3% | +0.6% | -0.8% | +5.2% | — |
| Aug 3, 2023 | AMC | 0.59 | 0.63 | +6.8% | 57.79 | +0.4% | -1.9% | +1.6% | -1.4% | -0.8% | +0.0% | — |
| May 4, 2023 | AMC | 0.51 | 0.53 | +3.9% | 56.59 | +2.8% | +3.3% | -0.5% | -2.6% | +1.3% | +0.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 | Wells Fargo | Maintains | Overweight → Overweight | — | $96.22 | $96.64 | +0.4% | +0.5% | -1.3% | -1.7% | -2.2% | -1.4% |
| Feb 25 | Barclays | Maintains | Overweight → Overweight | — | $91.88 | $92.33 | +0.5% | +4.7% | +0.5% | -1.3% | -1.7% | -2.2% |
| Feb 25 | Needham | Maintains | Buy → Buy | — | $91.88 | $92.33 | +0.5% | +4.7% | +0.5% | -1.3% | -1.7% | -2.2% |
| Jan 30 | Needham | Upgrade | Hold → Buy | — | $90.22 | $91.75 | +1.7% | +0.5% | -1.1% | -2.5% | -0.4% | +0.5% |
| Jan 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $94.62 | $95.77 | +1.2% | -0.2% | -2.9% | -1.7% | +2.6% | +1.5% |
| Jan 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $90.54 | $100.10 | +10.6% | +4.5% | -0.2% | -2.9% | -1.7% | +2.6% |
| Dec 17 | Canaccord Genuity | Maintains | Buy → Buy | — | $85.79 | $85.48 | -0.4% | -0.9% | +2.1% | +0.2% | +2.6% | -0.7% |
| Dec 17 | RBC Capital | Maintains | Outperform → Outperform | — | $85.79 | $85.48 | -0.4% | -0.9% | +2.1% | +0.2% | +2.6% | -0.7% |
| Dec 2 | Morgan Stanley | Maintains | Overweight → Overweight | — | $89.79 | $89.70 | -0.1% | -0.8% | -1.4% | +1.1% | +2.7% | -2.3% |
| Nov 18 | Truist | Maintains | Buy → Buy | — | $83.64 | $83.57 | -0.1% | -0.3% | +0.5% | -1.8% | +4.5% | +2.2% |
| Nov 10 | Barclays | Maintains | Overweight → Overweight | — | $83.89 | $83.37 | -0.6% | +2.9% | -1.6% | -0.3% | -0.8% | +0.5% |
| Nov 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $61.71 | $80.00 | +29.6% | +35.9% | +2.9% | -1.6% | -0.3% | -0.8% |
| Nov 7 | RBC Capital | Maintains | Outperform → Outperform | — | $61.71 | $80.00 | +29.6% | +35.9% | +2.9% | -1.6% | -0.3% | -0.8% |
| Nov 7 | BofA Securities | Upgrade | Neutral → Buy | — | $61.71 | $80.00 | +29.6% | +35.9% | +2.9% | -1.6% | -0.3% | -0.8% |
| Nov 7 | Truist | Upgrade | Hold → Buy | — | $61.71 | $80.00 | +29.6% | +35.9% | +2.9% | -1.6% | -0.3% | -0.8% |
| Oct 10 | RBC Capital | Maintains | Outperform → Outperform | — | $59.61 | $59.75 | +0.2% | -5.1% | +1.6% | +1.0% | +0.4% | +0.4% |
| Aug 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $54.07 | $56.00 | +3.6% | +8.5% | +1.3% | +4.1% | +1.5% | -4.4% |
| Jul 22 | Canaccord Genuity | Maintains | Buy → Buy | — | $51.89 | $52.22 | +0.6% | +2.2% | +1.9% | -1.4% | +2.2% | -0.3% |
| Jul 21 | Needham | Maintains | Hold → Hold | — | $56.34 | $53.36 | -5.3% | -7.9% | +2.2% | +1.9% | -1.4% | +2.2% |
| Jul 15 | Morgan Stanley | Maintains | Overweight → Overweight | — | $57.37 | $57.59 | +0.4% | -2.6% | +1.3% | +1.7% | -2.1% | -7.9% |
| May 27 | JMP Securities | Maintains | Market Perform → Market Perform | — | $58.96 | $59.71 | +1.3% | +1.1% | -0.6% | -0.5% | +0.5% | -0.4% |
| May 27 | BTIG | Downgrade | Buy → Neutral | — | $58.96 | $59.71 | +1.3% | +1.1% | -0.6% | -0.5% | +0.5% | -0.4% |
| May 12 | Truist | Maintains | Hold → Hold | — | $55.82 | $57.55 | +3.1% | +5.7% | -1.3% | -0.1% | -0.6% | +5.9% |
| May 9 | Piper Sandler | Maintains | Overweight → Overweight | — | $72.46 | $60.97 | -15.9% | -23.0% | +5.7% | -1.3% | -0.1% | -0.6% |
| May 9 | BTIG | Maintains | Buy → Buy | — | $72.46 | $60.97 | -15.9% | -23.0% | +5.7% | -1.3% | -0.1% | -0.6% |
| Apr 11 | Truist | Maintains | Hold → Hold | — | $70.98 | $70.78 | -0.3% | +2.3% | +0.5% | -0.9% | -1.7% | -0.2% |
| Apr 9 | BTIG | Maintains | Buy → Buy | — | $68.64 | $67.72 | -1.3% | +8.2% | -4.4% | +2.3% | +0.5% | -0.9% |
| Mar 18 | Needham | Maintains | Hold → Hold | — | $72.14 | $71.49 | -0.9% | -0.8% | +2.4% | +0.8% | -0.4% | +3.4% |
| Mar 18 | Truist | Maintains | Hold → Hold | — | $72.14 | $71.49 | -0.9% | -0.8% | +2.4% | +0.8% | -0.4% | +3.4% |
| Feb 24 | Citizens Capital Markets | Maintains | Market Perform → Market Perform | — | $80.28 | $79.90 | -0.5% | -0.3% | -0.5% | +0.5% | -1.7% | +2.1% |
| Feb 24 | Barclays | Maintains | Overweight → Overweight | — | $80.28 | $79.90 | -0.5% | -0.3% | -0.5% | +0.5% | -1.7% | +2.1% |
| Feb 21 | Needham | Maintains | Hold → Hold | — | $84.12 | $82.82 | -1.5% | -4.6% | -0.3% | -0.5% | +0.5% | -1.7% |
| Feb 21 | Wells Fargo | Maintains | Overweight → Overweight | — | $84.12 | $82.82 | -1.5% | -4.6% | -0.3% | -0.5% | +0.5% | -1.7% |
| Feb 21 | BTIG | Maintains | Buy → Buy | — | $84.12 | $82.82 | -1.5% | -4.6% | -0.3% | -0.5% | +0.5% | -1.7% |
| Feb 21 | Stifel | Maintains | Buy → Buy | — | $84.12 | $82.82 | -1.5% | -4.6% | -0.3% | -0.5% | +0.5% | -1.7% |
| Feb 6 | Needham | Maintains | Hold → Hold | — | $92.40 | $92.41 | +0.0% | -4.8% | -0.4% | -0.3% | -3.5% | -0.3% |
| Jan 10 | Canaccord Genuity | Maintains | Buy → Buy | — | $86.55 | $88.67 | +2.4% | +0.6% | +0.1% | +1.1% | +2.8% | -0.2% |
| Jan 9 | Needham | Maintains | Hold → Hold | — | — | — | — | — | — | — | — | — |
| Jan 9 | BofA Securities | Upgrade | Underperform → Neutral | — | — | — | — | — | — | — | — | — |
| Dec 18 | Truist | Maintains | Hold → Hold | — | $83.42 | $84.68 | +1.5% | -2.0% | +0.2% | +0.8% | +0.6% | +0.4% |
| Dec 17 | Roth MKM | Maintains | Buy → Buy | — | $81.70 | $81.70 | +0.0% | +2.1% | -2.0% | +0.2% | +0.8% | +0.6% |
| Dec 12 | BTIG | Maintains | Buy → Buy | — | $82.94 | $83.11 | +0.2% | -0.3% | -0.4% | -0.9% | +2.1% | -2.0% |
| Dec 11 | Wells Fargo | Maintains | Overweight → Overweight | — | $82.89 | $83.43 | +0.7% | +0.1% | -0.3% | -0.4% | -0.9% | +2.1% |
| Dec 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $83.32 | $83.47 | +0.2% | -0.5% | -0.0% | +0.1% | -0.3% | -0.4% |
| Dec 2 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $85.61 | $87.00 | +1.6% | -2.0% | +1.4% | -0.8% | -1.6% | +0.3% |
| Nov 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $80.88 | $82.18 | +1.6% | +1.4% | +1.7% | -1.1% | -1.7% | +0.0% |
| Nov 6 | Stifel | Maintains | Buy → Buy | — | $75.58 | $81.51 | +7.8% | +9.4% | -0.9% | -1.3% | +1.4% | +1.7% |
| Nov 6 | Roth MKM | Maintains | Buy → Buy | — | $75.58 | $81.51 | +7.8% | +9.4% | -0.9% | -1.3% | +1.4% | +1.7% |
| Nov 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $75.58 | $81.51 | +7.8% | +9.4% | -0.9% | -1.3% | +1.4% | +1.7% |
| Nov 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $75.58 | $81.51 | +7.8% | +9.4% | -0.9% | -1.3% | +1.4% | +1.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Davidar David D | — | Sell | 25,000 | $80.76 | $2.0M | 510,175 | -2.01% | +0.26% |
8-K · 5.02
!!! Very High
Globus Medical, Inc. -- 8-K 5.02: Executive Change
Jun 4
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
GMED's executive change, with Kelly G. taking a signing authority role as of March 2026, suggests potential leadership reorganization that could impact strategic direction and operational continuity for investors monitoring management stability.
Mar 23
8-K
GLOBUS MEDICAL INC -- 8-K Filing
Globus Medical reported full-year 2025 results showing musculoskeletal technology company performance, though specific financial metrics require review of detailed earnings data.
Feb 24
Institutional (13F) — Top 0
All ↗
No 13F holders found.
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$10.87B
Enterprise Value
$10.42B
P/E (TTM)
20.21x
Forward P/E
17.72x
PEG Ratio
0.05x
P/B
2.34x
P/S
3.70x
P/FCF
18.47x
EV/EBITDA
14.27x
Shares Out
137.2M
Financials (TTM)
Revenue
$2.94B
Net Income
$537.9M
EBITDA
$729.9M
Free Cash Flow
$588.8M
Op Cash Flow
$753.4M
EPS Basic
$3.98
EPS Diluted
$3.92
EPS Forward
$4.47
Gross Margin
67.4%
Op Margin
16.3%
Net Margin
18.3%
Balance Sheet
Total Assets
$5.30B
Total Liab.
$729.5M
Total Equity
$4.57B
Cash
$557.2M
LT Debt
$103.9M
Book Value/Sh
$33.84
Debt/Equity
0.03x
Current Ratio
4.26
Quick Ratio
2.74
Returns & Growth
ROE
11.8%
ROA
10.1%
ROIC
8.8%
Rev Growth YoY
+16.7%
EPS Growth YoY
+423.7%
Price Returns
2W
+6.0%
1M
-9.2%
3M
-14.2%
6M
-10.1%
12M
+38.4%
Technicals
52W High
$96.82
52W Low
$51.89
50d MA
$84.97
200d MA
$80.90
RSI (14)
44.30
ATR (14)
$2.35
Beta
1.09
Avg Volume
2.0M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$110.67
High
$115.00
Low
$100.00
Median
$112.00
Data updated apr 25, 2026 11:46am
· Source: financialmodelingprep.com